» Articles » PMID: 15966971

Hospital Outbreak Caused by a Carbapenem-resistant Strain of Acinetobacter Baumannii: Patient Prognosis and Risk-factors for Colonisation and Infection

Overview
Publisher Elsevier
Date 2005 Jun 22
PMID 15966971
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Between October 2001 and August 2002, 30 hospital patients became infected or colonised by a multiresistant (including to carbapenems) epidemic strain of Acinetobacter baumannii (AbMR) in a hospital outbreak. This study analysed the risk-factors associated with acquisition of this epidemic strain and investigated the prognosis of patients infected by AbMR, with the aim of elucidating factors which lead to mortality. A case-control study of the acquisition of AbMR in patients infected or colonised in the hospital outbreak was performed. Independent risk-factors leading to death were studied by logistic regression analysis. Multivariate analysis of the risk-factors for colonisation/infection with AbMR revealed an independent association with the presence of an arterial catheter (OR, 1.13; 95% CI, 1.03-1.25) and administration of imipenem as monotherapy (OR, 11.12; 95% CI, 2.33-53.09). Multivariate analysis of the prognostic features leading to mortality revealed a significant association with hypotension or shock (OR, 24.63; 95% CI, 1.56-387.56) at the time of bacterial isolation.

Citing Articles

The Global and Regional Prevalence of Hospital-Acquired Carbapenem-Resistant Infection: A Systematic Review and Meta-analysis.

Lin X, Li C, Zhang S, Yang X, Jiang M Open Forum Infect Dis. 2024; 11(2):ofad649.

PMID: 38312215 PMC: 10836986. DOI: 10.1093/ofid/ofad649.


Inferring bacterial transmission dynamics using deep sequencing genomic surveillance data.

Senghore M, Read H, Oza P, Johnson S, Passarelli-Araujo H, Taylor B Nat Commun. 2023; 14(1):6397.

PMID: 37907520 PMC: 10618251. DOI: 10.1038/s41467-023-42211-8.


Risk factors for acquiring infection in the intensive care unit: experience from a Moroccan hospital.

Benaissa E, Belouad E, Maleb A, Elouennass M Access Microbiol. 2023; 5(8).

PMID: 37691842 PMC: 10484316. DOI: 10.1099/acmi.0.000637.v3.


comparison of V.A.C.® Granufoam Silver™ and V.A.C.® Granufoam™ loaded with a first-in-class bis-dialkylnorspermidine-terphenyl antibiofilm agent.

Rawson K, Neuberger T, Smith T, Bell I, Looper R, Sebahar P Biofilm. 2023; 6:100142.

PMID: 37484784 PMC: 10359492. DOI: 10.1016/j.bioflm.2023.100142.


Epidemiological and Antimicrobial Resistant Patterns, and Molecular Mechanisms of Carbapenem-Resistant Infections in ICU Patients.

Lu F, Zhang L, Ji J, Xu Y, Wang B, Xia J Infect Drug Resist. 2023; 16:2813-2827.

PMID: 37193299 PMC: 10182806. DOI: 10.2147/IDR.S410657.